Angola vs Mali: Cause of death, by non-communicable diseases, ages 0-4, female
Angola
5.6%
in 2021
Mali
5.3%
in 2021
Angola rank
171st
Mali rank
174th
Cause of death, by non-communicable diseases, ages 0-4, female over time
- Angola
- Mali
How they compare
Angola currently reports 5.6% against 5.3% in Mali, a difference of 0.3%.
That makes Angola's figure about 1.1 times Mali's.
Across all 6 years both countries report, Angola has been ahead every year.
Angola ranks 171st and Mali ranks 174th of 185 countries.
Angola has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Angola | Mali | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.6% | 3.4% | 0.2% | Angola |
| 2010s | 6.0% | 5.0% | 1.1% | Angola |
| 2020s | 5.8% | 5.1% | 0.7% | Angola |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, female, Angola or Mali?
- Angola, at 5.6% against 5.3% in Mali as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, female between Angola and Mali?
- 0.3%, with Angola ahead.
- How many years of comparable data are there for Angola and Mali?
- 6 years are reported by both, from 2000 to 2021.
- How do Angola and Mali rank globally for cause of death, by non-communicable diseases, ages 0-4, female?
- Angola ranks 171st and Mali ranks 174th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.